|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.79 USD | +1.00% |
|
+1.99% | +21.28% |
| 01-14 | UBS Adjusts Celsius Holdings Price Target to $70 From $65, Maintains Buy Rating | MT |
| 12-17 | KeyBanc Initiates Celsius Holdings at Sector Weight | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.46 | -1.15 | -12.64 | 12.07 | 5.9 | |||||
Return on Total Capital | 5.54 | -1.58 | -17.9 | 17.02 | 8.35 | |||||
Return On Equity % | 10.16 | 2.45 | -34.63 | 23.22 | 12.54 | |||||
Return on Common Equity | 10.16 | 2.45 | -154.63 | 119.68 | 32.37 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 46.64 | 40.78 | 41.44 | 48.04 | 50.18 | |||||
SG&A Margin | 40.59 | 42.08 | 65.2 | 27.59 | 38.07 | |||||
EBITDA Margin % | 6.94 | -0.9 | -23.47 | 20.45 | 12.05 | |||||
EBITA Margin % | 6.5 | -1.11 | -23.68 | 20.25 | 11.55 | |||||
EBIT Margin % | 6.05 | -1.3 | -23.76 | 20.21 | 11.51 | |||||
Income From Continuing Operations Margin % | 6.52 | 1.25 | -28.65 | 17.21 | 10.7 | |||||
Net Income Margin % | 6.52 | 1.25 | -28.65 | 17.21 | 10.7 | |||||
Net Avail. For Common Margin % | 6.52 | 1.25 | -30.42 | 13.81 | 7.93 | |||||
Normalized Net Income Margin | 4.1 | -0.81 | -14.36 | 13.83 | 9.01 | |||||
Levered Free Cash Flow Margin | -0.95 | -31.04 | -10.17 | 11.95 | 15.95 | |||||
Unlevered Free Cash Flow Margin | -0.9 | -31.04 | -10.17 | 11.95 | 15.95 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.18 | 1.41 | 0.85 | 0.96 | 0.82 | |||||
Fixed Assets Turnover | 103.76 | 105.25 | 82.95 | 68.65 | 25.95 | |||||
Receivables Turnover (Average Receivables) | 11.49 | 11.7 | 12.81 | 10.67 | 5.97 | |||||
Inventory Turnover (Average Inventory) | 4.14 | 1.78 | 2.1 | 3.4 | 3.75 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.53 | 2.82 | 5.69 | 4.36 | 3.62 | |||||
Quick Ratio | 2.21 | 0.59 | 4.2 | 3.4 | 3.17 | |||||
Operating Cash Flow to Current Liabilities | 0.13 | -1.04 | 0.67 | 0.51 | 0.72 | |||||
Days Sales Outstanding (Average Receivables) | 31.86 | 31.2 | 28.49 | 34.2 | 61.29 | |||||
Days Outstanding Inventory (Average Inventory) | 88.4 | 205.57 | 173.81 | 107.27 | 97.66 | |||||
Average Days Payable Outstanding | 55.29 | 27.03 | 43.11 | 24.54 | 34.78 | |||||
Cash Conversion Cycle (Average Days) | 64.98 | 209.74 | 159.19 | 116.94 | 124.17 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.08 | 0.63 | 0.14 | 0.2 | 1.65 | |||||
Total Debt / Total Capital | 1.07 | 0.63 | 0.14 | 0.2 | 1.63 | |||||
LT Debt/Equity | 0.57 | 0.32 | 0.06 | 0.11 | 1.38 | |||||
Long-Term Debt / Total Capital | 0.57 | 0.32 | 0.06 | 0.11 | 1.36 | |||||
Total Liabilities / Total Assets | 20.54 | 30.88 | 29.25 | 29.15 | 30.7 | |||||
EBIT / Interest Expense | 7.72 | -544.91 | - | - | - | |||||
EBITDA / Interest Expense | 9.23 | -313.06 | - | - | - | |||||
(EBITDA - Capex) / Interest Expense | 8.67 | -732.82 | - | - | - | |||||
Total Debt / EBITDA | 0.12 | -0.58 | -0.01 | 0.01 | 0.12 | |||||
Net Debt / EBITDA | -4.45 | 6.33 | 4.01 | -2.8 | -5.26 | |||||
Total Debt / (EBITDA - Capex) | 0.13 | -0.25 | -0.01 | 0.01 | 0.14 | |||||
Net Debt / (EBITDA - Capex) | -4.74 | 2.71 | 3.8 | -2.99 | -6.12 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 73.96 | 140.41 | 107.97 | 101.65 | 2.85 | |||||
Gross Profit, 1 Yr. Growth % | 94.79 | 110.2 | 111.34 | 133.74 | 7.43 | |||||
EBITDA, 1 Yr. Growth % | -806.64 | -131.59 | 5.33K | -275.62 | -39.43 | |||||
EBITA, 1 Yr. Growth % | -686.42 | -141 | 4.34K | -272.26 | -41.31 | |||||
EBIT, 1 Yr. Growth % | -646.17 | -151.69 | 3.7K | -271.38 | -41.42 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -14.52 | -53.81 | -4.86K | -221.1 | -36.03 | |||||
Net Income, 1 Yr. Growth % | -14.52 | -53.81 | -4.86K | -221.1 | -36.03 | |||||
Normalized Net Income, 1 Yr. Growth % | -444.18 | -147.36 | 3.6K | -294.13 | -33.04 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -32.91 | -54.49 | -5.35K | -187.47 | -41.12 | |||||
Accounts Receivable, 1 Yr. Growth % | 92.76 | 158.51 | 63.42 | 190.16 | 47.16 | |||||
Inventory, 1 Yr. Growth % | 20.35 | 939.04 | -9.38 | 32.31 | -42.79 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 67.4 | 178.55 | 158.65 | 137.86 | 186.46 | |||||
Total Assets, 1 Yr. Growth % | 45.26 | 139.18 | 289.17 | 25.72 | 15 | |||||
Tangible Book Value, 1 Yr. Growth % | 113.22 | 140.85 | -92.4 | 1.58K | 32.98 | |||||
Common Equity, 1 Yr. Growth % | 64.4 | 108.04 | -81.53 | 558.6 | 51.47 | |||||
Cash From Operations, 1 Yr. Growth % | 228.35 | -2.94K | -212.01 | 30.54 | 86.16 | |||||
Capital Expenditures, 1 Yr. Growth % | 635.82 | 449.08 | 162.35 | 110.95 | 34.17 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -125.52 | 7.05K | -31.88 | -336.76 | 37.28 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -123.99 | 7.4K | -31.88 | -336.76 | 37.28 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 57.64 | 104.5 | 123.6 | 104.79 | 44.02 | |||||
Gross Profit, 2 Yr. CAGR % | 70.15 | 102.35 | 110.77 | 122.26 | 58.47 | |||||
EBITDA, 2 Yr. CAGR % | -2.62 | 48.36 | 301.33 | 876.71 | 3.14 | |||||
EBITA, 2 Yr. CAGR % | -6.14 | 55.21 | 326.45 | 774.45 | 0.55 | |||||
EBIT, 2 Yr. CAGR % | -9.41 | 68.03 | 343.04 | 707.01 | 0.19 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -12.79 | -37.16 | 368.73 | 659 | -11.99 | |||||
Net Income, 2 Yr. CAGR % | -12.79 | -37.16 | 368.73 | 659 | -11.99 | |||||
Normalized Net Income, 2 Yr. CAGR % | -6.63 | 27.67 | 318.59 | 747.8 | 14.01 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -30.83 | -44.75 | 388.76 | 557.87 | -28.23 | |||||
Accounts Receivable, 2 Yr. CAGR % | 7.45 | 123.23 | 105.54 | 117.76 | 106.64 | |||||
Inventory, 2 Yr. CAGR % | 26.6 | 253.62 | 206.86 | 9.5 | -13 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 259.81 | 115.94 | 168.41 | 148.04 | 161.03 | |||||
Total Assets, 2 Yr. CAGR % | 94.72 | 86.4 | 205.09 | 121.19 | 20.24 | |||||
Tangible Book Value, 2 Yr. CAGR % | 155.94 | 126.61 | -57.21 | 12.99 | 372.54 | |||||
Common Equity, 2 Yr. CAGR % | 197.31 | 84.94 | -38.01 | 10.3 | 215.84 | |||||
Cash From Operations, 2 Yr. CAGR % | -46.01 | 866.5 | 464.49 | 20.92 | 55.89 | |||||
Capital Expenditures, 2 Yr. CAGR % | 127.95 | 535.63 | 279.44 | 135.25 | 68.24 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -58.28 | 348.61 | 590.03 | 27.07 | 80.28 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -59.03 | 346.56 | 857.76 | 27.07 | 80.28 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 53.47 | 81.45 | 105.65 | 116.03 | 62.78 | |||||
Gross Profit, 3 Yr. CAGR % | 58.1 | 82.57 | 105.3 | 118.16 | 74.43 | |||||
EBITDA, 3 Yr. CAGR % | 4.03 | -33.4 | 392.5 | 204.77 | 286.61 | |||||
EBITA, 3 Yr. CAGR % | 1.68 | -28.73 | 374.56 | 215.32 | 255.37 | |||||
EBIT, 3 Yr. CAGR % | -0.7 | -24.86 | 375.07 | 222.9 | 236.64 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 1.13 | -29.44 | 165.82 | 198.54 | 232.77 | |||||
Net Income, 3 Yr. CAGR % | 1.13 | -29.44 | 165.82 | 198.54 | 232.77 | |||||
Normalized Net Income, 3 Yr. CAGR % | 1.31 | -25.54 | 292.16 | 224.1 | 263.75 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -17.17 | -39.84 | 152.13 | 175.78 | 194.27 | |||||
Accounts Receivable, 3 Yr. CAGR % | 32.96 | 43.98 | 101.19 | 130.57 | 91.09 | |||||
Inventory, 3 Yr. CAGR % | 51.38 | 155.37 | 124.61 | 131.82 | -11.81 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 193.11 | 230.38 | 129.33 | 157.81 | 160.23 | |||||
Total Assets, 3 Yr. CAGR % | 69.19 | 108.53 | 138.23 | 127.03 | 77.86 | |||||
Tangible Book Value, 3 Yr. CAGR % | 65.21 | 150.81 | -26.91 | 45.41 | 19.29 | |||||
Common Equity, 3 Yr. CAGR % | 82.56 | 163.95 | -14.19 | 36.28 | 22.6 | |||||
Cash From Operations, 3 Yr. CAGR % | -26.12 | 102.41 | 371.21 | 246.48 | 39.62 | |||||
Capital Expenditures, 3 Yr. CAGR % | 126.26 | 205.57 | 373.24 | 212 | 95.09 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -38.79 | 139.43 | 139.33 | 383.26 | 30.38 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -39.48 | 140.77 | 138.61 | 501.32 | 30.39 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 49.99 | 69.05 | 78.41 | 90.45 | 78.34 | |||||
Gross Profit, 5 Yr. CAGR % | 54 | 67.47 | 77.37 | 97.52 | 85.1 | |||||
EBITDA, 5 Yr. CAGR % | 38.28 | -0.01 | 80.26 | 94.97 | 163.56 | |||||
EBITA, 5 Yr. CAGR % | 35.97 | 4.17 | 80.5 | 94.28 | 155.15 | |||||
EBIT, 5 Yr. CAGR % | 34.05 | 7.53 | 80.61 | 94.21 | 154.95 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 31.72 | 5.12 | 86.77 | 82.49 | 70.83 | |||||
Net Income, 5 Yr. CAGR % | 31.72 | 5.12 | 86.77 | 82.49 | 70.83 | |||||
Normalized Net Income, 5 Yr. CAGR % | 31.86 | 5.72 | 78.7 | 97.01 | 139.29 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 7.28 | -10.86 | 68.48 | 58.6 | 52.64 | |||||
Accounts Receivable, 5 Yr. CAGR % | 47.77 | 69.27 | 58.27 | 69.89 | 103.35 | |||||
Inventory, 5 Yr. CAGR % | 51.28 | 143.99 | 100.82 | 82 | 53.7 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 136.51 | 165.14 | 182.97 | 194.59 | 141.52 | |||||
Total Assets, 5 Yr. CAGR % | 53.78 | 77.71 | 114.19 | 113.51 | 81.23 | |||||
Tangible Book Value, 5 Yr. CAGR % | 54.64 | 76.43 | -3.76 | 82.31 | 54.2 | |||||
Common Equity, 5 Yr. CAGR % | 64.19 | 81.91 | 18.51 | 86.18 | 44.51 | |||||
Cash From Operations, 5 Yr. CAGR % | 35.07 | 110.03 | 66.64 | 64.72 | 202.73 | |||||
Capital Expenditures, 5 Yr. CAGR % | 122.97 | 152.28 | 178.26 | 175.21 | 212.91 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 90.95 | 156.69 | 65.24 | 85.83 | 113.74 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 36.22 | 166 | 65.86 | 86.46 | 113.35 |
- Stock Market
- Equities
- CELH Stock
- Financials Celsius Holdings, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















